ReWalk Robotics (RWLK) Reports Q4 Loss of $0.25/Share
ReWalk Robotics (NASDAQ: RWLK) reported Q4 EPS of ($0.25), versus ($0.56) reported last year. Revenue for the quarter came in at $1.52 million, versus $1.59 million reported last year.
In 2018, we expect to achieve sales of between $9 million and $11 million of SCI exoskeletons. The pace of VA support for veterans and reimbursement outcomes will be key drivers during the year. Any sales of the Restore, once cleared, would be additive.
For earnings history and earnings-related data on ReWalk Robotics (RWLK) click here.